WE AIM TO CONDUCT A RANDOMIZED, CONTROLLED CLINICAL TRIAL IN CRITICALLY ILL PATIENTS WITH SEVERE PNEUMONIA RECEIVING BETA-LACTAM THERAPY AS CONTINUOUS VS. INTERMITTENT INFUSION FOR GRAM-NEGATIVE INFECTIONS AND ASSESS THE DEVELOPMENT OF NEW BACTERIA

DEFINITIVE CONTRACT won by UNIVERSITY OF FLORIDA · work in SILVER SPRING, MD
$499,445
RecipientUNIVERSITY OF FLORIDA UEI NNFQH1JAPEP3
Award ID75F40121C00157
Award amount$499,445
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Food and Drug Administration
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN11
Set-asideUnrestricted
Start dateSep 28, 2021
End dateSep 29, 2023
Place of performanceSILVER SPRING, MD
Record updatedApr 2, 2022

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids